Medications for Rhizomelic Pseudopolyarthritis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Rhizomelic Pseudopolyarthritis.
Found 1 Approved Drug for Rhizomelic Pseudopolyarthritis
Kevzara
Generic Name
Sarilumab
Kevzara
Generic Name
Sarilumab
Form: Injection
Method of administration: Subcutaneous
FDA approval date: May 22, 2017
Classification: Interleukin-6 Receptor Antagonist
KEVZARA ® is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of: adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances